Miltefosine in visceral leishmaniasis.
作者信息
Olliaro Piero L, Ridley Robert G, Engel Jurgen, Sindermann Herbert, Bryceson Anthony D M
出版信息
Lancet Infect Dis. 2003 Feb;3(2):70. doi: 10.1016/s1473-3099(03)00512-7.
Abstract
摘要
相似文献
1
Miltefosine in visceral leishmaniasis.米替福新治疗内脏利什曼病
Lancet Infect Dis. 2003 Feb;3(2):70. doi: 10.1016/s1473-3099(03)00512-7.
2
Miltefosine--the long-awaited therapy for visceral leishmaniasis?米替福新——内脏利什曼病期待已久的治疗方法？
N Engl J Med. 1999 Dec 9;341(24):1840-2. doi: 10.1056/NEJM199912093412411.
3
Short-course of oral miltefosine for treatment of visceral leishmaniasis.口服米替福新短疗程治疗内脏利什曼病
Clin Infect Dis. 2000 Oct;31(4):1110-3. doi: 10.1086/318122.
4
[Treatment of visceral leishmaniasis: efficacy and limits of miltefosine].[内脏利什曼病的治疗：米替福新的疗效与局限性]
Sante. 2001 Oct-Dec;11(4):257-8.
5
Fatal acute pancreatitis in a patient with visceral leishmaniasis during miltefosine treatment.一名内脏利什曼病患者在米替福新治疗期间发生致命性急性胰腺炎。
J Postgrad Med. 2013 Oct-Dec;59(4):306-8. doi: 10.4103/0022-3859.123161.
6
Miltefosine Induced Reduced Male Fertility Capacity after Treatment of Post Kala-azar Dermal Leishmaniasis, Bangladesh.孟加拉国治疗黑热病后皮肤利什曼病后米替福新导致男性生育能力下降
Mymensingh Med J. 2019 Apr;28(2):328-332.
7
[Visceral leishmaniasis: a new oral treatment?].[内脏利什曼病：一种新的口服治疗方法？]
Arch Pediatr. 1999 Jun;6(6):687-8. doi: 10.1016/s0929-693x(99)80305-4.
8
Comparison of cardiotoxicity between N-methyl-glucamine and miltefosine in the treatment of American cutaneous leishmaniasis.N-甲基葡糖胺与米替福新治疗美洲皮肤利什曼病时心脏毒性的比较。
An Bras Dermatol. 2021 Jul-Aug;96(4):502-504. doi: 10.1016/j.abd.2021.02.002. Epub 2021 May 15.
9
Oral miltefosine treatment in children with visceral leishmaniasis: a brief review.儿童内脏利什曼病的口服米替福新治疗：简要综述
Braz J Infect Dis. 2008 Feb;12(1):2-4. doi: 10.1590/s1413-86702008000100002.
10
Combination therapy for visceral leishmaniasis.内脏利什曼病的联合治疗
Lancet. 2011 Feb 5;377(9764):443-4. doi: 10.1016/S0140-6736(10)62237-4. Epub 2011 Jan 20.
Zotero 插件